Skip to main content

letter

. 1993 May 8;306(6887):1271. doi: 10.1136/bmj.306.6887.1271-b

Gangliosides in neurological diseases.

R A Hughes, N A Gregson

PMCID: PMC1677590 PMID: 8499868

1271

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Fredman P., Vedeler C. A., Nyland H., Aarli J. A., Svennerholm L. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin. J Neurol. 1991 Apr;238(2):75–79. doi: 10.1007/BF00315684. [DOI] [PubMed] [Google Scholar]
Gibbs C. J., McKhann G. M., Walsh F. S., Yu R. K. Gangliosides in neurological diseases. BMJ. 1993 Mar 6;306(6878):655–656. doi: 10.1136/bmj.306.6878.655-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
Gregson N. A., Koblar S., Hughes R. A. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Q J Med. 1993 Feb;86(2):111–117. [PubMed] [Google Scholar]
Santoro M., Uncini A., Corbo M., Staugaitis S. M., Thomas F. P., Hays A. P., Latov N. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol. 1992 Apr;31(4):385–390. doi: 10.1002/ana.410310407. [DOI] [PubMed] [Google Scholar]
Willison H. J., Veitch J., Paterson G., Kennedy P. G. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):204–206. doi: 10.1136/jnnp.56.2.204. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES